Xanthine

Xanthine

SCHEMBL3193095

Cn1c(=O)c2c(n(C)c1=O)n(C)c(=O)n2C.O=c1[nH]c(=O)c2[nH]cnc2[nH]1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GDA Q9Y2T3 2/20 0.62
ACHE P22303 1/20 0.62
ADORA2A P29274 9/20 0.49
ADORA2B P29275 6/20 0.49
ATAD2 Q6PL18 1/20 0.47
PDE4A P27815 8/20 0.46
PDE4B Q07343 8/20 0.46
PDE4C Q08493 8/20 0.46
PDE4D Q08499 8/20 0.46
ADORA3 P0DMS8 4/20 0.46
ADORA1 P30542 3/20 0.46
PIK3CD O00329 1/20 0.46
ALPL P05186 1/20 0.46
TMIGD3 P0DMS9 1/20 0.46
CYP2C19 P33261 1/20 0.46
HIF1A Q16665 1/20 0.46
CYP1A2 P05177 2/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Theophylline Anhydrous SCHEMBL4408878 0.84 ATAD2 (0.70) GDAACHEADORA2AADORA2BATAD2
Caffeine SCHEMBL2355447 0.84 ADORA2A (0.59) GDAACHEADORA2AADORA2BATAD2
1-Methylxanthine SCHEMBL16859909 0.79 ADORA2B (0.79) GDAACHEADORA2AADORA2BATAD2
Xanthine SCHEMBL2352524 0.79 GDA (1.00) GDAACHEADORA2AADORA2BPDE4A
Xanthine SCHEMBL4965 0.79 GDA (1.00) GDAACHEADORA2AADORA2BPDE4A
Xanthine SCHEMBL29669592 0.79 GDA (1.00) GDAACHEADORA2AADORA2BPDE4A
Theophylline Anhydrous SCHEMBL1172658 0.79 CYP1A2 (0.74) GDAACHEADORA2AADORA2BATAD2
Xanthine SCHEMBL7044227 0.77 GDA (0.96) GDAACHEADORA2AADORA2BPDE4A
Xanthine SCHEMBL1507586 0.77 GDA (0.96) GDAACHEADORA2AADORA2BPDE4A
Xanthine SCHEMBL7044230 0.77 GDA (0.96) GDAACHEADORA2AADORA2BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662767-B2 Polynucleotide intercalator interceptors and inhibitors MATERIALS EVOLUTION AND DEVELOPMENT USA, INC. (US) 2010-02-16 US disclosed
US-20050065335-A1 Polynucleotide intercalator interceptors and inhibitors MATERIALS EVOLUTION AND DEVELOPMENT USA, INC 2005-03-24 US disclosed
EP-1318796-A2 POLYNUCLEOTIDE INTERCALATOR INTERCEPTORS AND INHIBITORS Lyles, Mark B. (US) 2003-06-18 EP disclosed
WO-2002045707-A2 POLYNUCLEOTIDE INTERCALATOR INTERCEPTORS AND INHIBITORS LYLES MARK B (US) 2002-06-13 WO disclosed